Michael Catlin Kiromic Biopharma, Inc. (KRBP) insider trading activity
Michael Catlin is Director of Kiromic Biopharma, Inc.. Currently has a direct ownership of 25,500 shares of KRBP, which is worth approximately $23,460. The most recent transaction as insider was on Mar 18, 2024, when has been sold 18,000 shares (Restricted Stock Award) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25.5K
0%
3M change
n/a
12M change
Total Value Held
$23,460
MC
Michael Catlin
Director
Houston, TX